CLGN and hepatocellular carcinoma: A recent study reported that upregulation of CLGN in HCC is significantly related to poor prognosis, especially in advanced stages which might be regulated by miR-194-3p, thus providing a potentially therapeutic target and prognosis predictor in HCC [39].